Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-05-15

Clinical Trial Update: A Pharmacokinetic Study to Compare Co-administration of Repaglinide and Metformin HCl to Administration of Combination Preparation of Those Two Components [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic trial comparing co-administration of repaglinide with metformin HCl to a fixed-combination preparation. The study enrolled adults with t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METFORMIN HCL (METFORMIN HYDROCHLORIDE)
  • Repaglinide (Repaglinide)

Snippet

Sponsor: Dalim BioTech Co., Ltd. | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED